2) #BA5 and #BA4 are worrisome. They are surging and they have high reinfection potential. Your past BA1/BA2 doesn’t substantially protect you from #Ba5/4 https://t.co/soX1ygq9lN
— Eric Feigl-Ding (@DrEricDing) June 13, 2022
4) Is it a Paxlovid rebound for Becerra, as some are asking? Unclear−Paxlovid rebound usually only happens at day 10-14 that we know of and have data. The FDA says it’s 1-2% rebound but I counted 12% from this Pfizer graph submitted to FDA. https://t.co/lgzWqY7WON
— Eric Feigl-Ding (@DrEricDing) June 13, 2022
米国でのBA.4およびBA.5の検出率はすでに13%に達しているとの報道。BA.1&BA.2の遅行期間を見ると日本と韓国でも1か月〜1か月半ほど遅れて再拡大が始まるかもしれない。最も重要なのは、流行してみなければ、どの程度の被害となるのかわからないこと。各国の検疫は緩み切っている。入国時PCRは必須だ。
— Kanayama Kohei (@koheikana) June 13, 2022